| Schedule of Earnings Per Share, Basic and Diluted |
The following table summarizes the computation of basic and diluted earnings per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
THREE MONTHS ENDED |
|
NINE MONTHS ENDED |
|
March 31, |
|
March 31, |
|
2014 |
|
2013 |
|
2014 |
|
2013 |
|
(In thousands, except share and per share amounts) |
Loss from continuing operations |
$ |
(3,073 |
) |
|
$ |
(3,726 |
) |
|
$ |
(9,364 |
) |
|
$ |
(11,364 |
) |
Preferred stock dividend |
(431 |
) |
|
— |
|
|
(1,267 |
) |
|
— |
|
Net loss |
(3,504 |
) |
|
(3,726 |
) |
|
(10,631 |
) |
|
(11,364 |
) |
Net income (loss) from discontinued operations |
27,593 |
|
|
(606 |
) |
|
24,937 |
|
|
(5,564 |
) |
Net income (loss) attributable to common stockholders |
$ |
24,089 |
|
|
$ |
(4,332 |
) |
|
$ |
14,306 |
|
|
$ |
(16,928 |
) |
|
|
|
|
|
|
|
|
Basic weighted average shares outstanding |
45,348,709 |
|
|
46,084,149 |
|
|
45,348,753 |
|
|
51,302,369 |
|
Add: dilutive effects of in-the-money stock options and non-vested restricted stock grants (1)
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Diluted weighted average common shares outstanding |
45,348,709 |
|
|
46,084,149 |
|
|
45,348,753 |
|
|
51,302,369 |
|
|
|
|
|
|
|
|
|
Basic earnings (loss) per common share: |
|
|
|
|
|
|
|
Loss from continuing operations |
$(0.07) |
|
$(0.08) |
|
$(0.21) |
|
$(0.22) |
Net income (loss) from discontinued operations |
$0.61 |
|
$(0.01) |
|
$0.55 |
|
$(0.11) |
Net income (loss) attributable to common stockholders |
$0.53 |
|
$(0.09) |
|
$0.32 |
|
$(0.33) |
|
|
|
|
|
|
|
|
Diluted earnings (loss) per common share: |
|
|
|
|
|
|
|
Loss from continuing operations |
$(0.07) |
|
$(0.08) |
|
$(0.21) |
|
$(0.22) |
Net income (loss) from discontinued operations |
$0.61 |
|
$(0.01) |
|
$0.55 |
|
$(0.11) |
Net income (loss) attributable to common stockholders |
$0.53 |
|
$(0.09) |
|
$0.32 |
|
$(0.33) |
|
| Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share |
Potentially dilutive securities excluded from the calculation of diluted shares outstanding in periods with net losses are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
THREE MONTHS ENDED |
|
NINE MONTHS ENDED |
|
March 31, |
|
March 31, |
|
2014 |
|
2013 |
|
2014 |
|
2013 |
In-the-money stock options |
5,143,666 |
|
|
75,000 |
|
|
907,500 |
|
|
82,500 |
|
Non-vested restricted stock |
850,000 |
|
|
— |
|
|
900,000 |
|
|
— |
|
Total |
5,993,666 |
|
|
75,000 |
|
|
1,807,500 |
|
|
82,500 |
|
|